Par Infringed Ferring Colonoscopy Drug IP, Says Del. Judge
A Delaware federal judge ruled Tuesday that Par Pharmaceutical Inc.'s new drug application for a generic version of Ferring Pharmaceuticals Inc.'s colonoscopy treatment Prepopik infringed Ferring's patents, weighing Ferring's expert testimony...To view the full article, register now.
Already a subscriber? Click here to view full article